AVDL (Avadel Pharmaceuticals plc Ordinary Share)
Insider Trading Activity
Every open-market purchase and sale reported by AVDL officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-12 | Susan Rodriguez | Chief Operating Officer | D | — | — |
| 2026-02-12 | Naseem Amin | Director | D | — | — |
| 2026-02-12 | Peter J. Thornton | Director | D | — | — |
| 2026-02-12 | Eric J Ende | Director | D | — | — |
| 2026-02-12 | THOMAS S MCHUGH | Chief Financial Officer | D | — | — |
| 2026-02-12 | Jerad G. Seurer | Gen. Counsel & Corp. Secretary | D | — | — |
| 2026-02-12 | Gregory J Divis | Chief Executive Officer | D | — | — |
| 2026-02-12 | Geoffrey Michael Glass | Director | D | — | — |
| 2026-02-12 | Linda Palczuk | Director | D | — | — |
| 2026-02-12 | Mark Anthony McCamish | Director | D | — | — |
| 2026-02-06 | Mark Anthony McCamish | Director | G | — | — |
| 2025-09-15 | Linda Palczuk | Director | G | — | — |
| 2025-09-15 | Geoffrey Michael Glass | Director | G | — | — |
| 2025-07-31 | Linda Palczuk | Director | A | — | — |
| 2025-07-31 | Eric J Ende | Director | A | — | — |
| 2025-07-31 | Peter J. Thornton | Director | A | — | — |
| 2025-07-31 | Mark Anthony McCamish | Director | A | — | — |
| 2025-07-31 | Naseem Amin | Director | A | — | — |
| 2025-07-31 | Geoffrey Michael Glass | Director | A | — | — |
| 2025-05-13 | Susan Rodriguez | Chief Operating Officer | A | — | — |
| 2025-03-07 | THOMAS S MCHUGH | Chief Financial Officer | A | — | — |
| 2025-03-07 | Jerad G. Seurer | Gen. Counsel & Corp. Secretary | A | — | — |
| 2025-03-07 | Gregory J Divis | Chief Executive Officer | A | — | — |
| 2025-01-28 | Linda Palczuk | Director | G | — | — |
| 2025-01-22 | Linda Palczuk | Director | Buy | — | — |
| 2025-01-14 | Peter J. Thornton | Director | Buy | — | — |
| 2025-01-14 | Eric J Ende | Director | Buy | — | — |
| 2024-12-27 | Linda Palczuk | Director | G | — | — |
| 2024-12-19 | Linda Palczuk | Director | A | — | — |
| 2024-12-16 | THOMAS S MCHUGH | Chief Financial Officer | Buy | — | — |
| 2024-12-12 | THOMAS S MCHUGH | Chief Financial Officer | Buy | — | — |
| 2024-12-10 | Linda Palczuk | Director | Buy | — | — |
| 2024-12-10 | Gregory J Divis | Chief Executive Officer | Buy | — | — |
| 2024-12-10 | Geoffrey Michael Glass | Director | Buy | — | — |
| 2024-09-16 | Linda Palczuk | Director | G | — | — |
| 2024-09-13 | Geoffrey Michael Glass | Director | G | — | — |
| 2024-08-01 | Mark Anthony McCamish | Director | A | — | — |
| 2024-08-01 | Linda Palczuk | Director | A | — | — |
| 2024-08-01 | Geoffrey Michael Glass | Director | A | — | — |
| 2024-08-01 | Eric J Ende | Director | A | — | — |
| 2024-08-01 | Peter J. Thornton | Director | A | — | — |
| 2024-08-01 | Naseem Amin | Director | A | — | — |
| 2024-05-21 | Naseem Amin | Director | A | — | — |
| 2024-03-04 | Gregory J Divis | Chief Executive Officer | A | — | — |
| 2024-03-04 | THOMAS S MCHUGH | Chief Financial Officer | A | — | — |
| 2024-03-04 | Richard J Kim | Chief Commercial Officer | A | — | — |
| 2024-01-16 | THOMAS S MCHUGH | Chief Financial Officer | Buy | — | — |
| 2023-12-29 | Mark Anthony McCamish | Director | Sell | — | — |
| 2023-09-01 | Geoffrey Michael Glass | Director | G | — | — |
| 2023-09-01 | Linda Palczuk | Director | G | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | 10%+ Owner | 4,133,464 | — |
| — | Director | 3,130,573 | — |
| — | Director | 3,130,573 | — |
| — | — | 952,265 | — |
| — | Director | 588,628 | — |
| — | Chief Executive Officer | 248,953 | — |
| — | See Remarks | 113,671 | — |
| — | See Remarks | 59,165 | — |
| — | See Remarks | 56,000 | — |
| — | See Remarks | 50,538 | — |
| — | See Remarks | 32,500 | — |
| — | See Remarks | 30,000 | — |
| — | Director | 26,365 | — |
| — | Director | 26,365 | — |
| — | Director | 26,365 | — |
| — | Director | 23,440 | — |
| — | VP Irish & European Operations | 15,000 | — |
| — | See Remarks | 10,000 | — |
| — | Controller & CAO | 4,083 | — |
| — | See Remarks | 3,400 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the AVDL quote page; the site-wide leaderboard is on the insider transactions hub.